FOI_6687

Internal Reference Number: FOI_6687

Date Request Received: 19/07/2022 00:00:00

Date Request Replied To: 04/08/2022 00:00:00

This response was sent via: By Email

Request Summary: Oesophageal and Gastric cancer

Request Category: Companies


Question Number 1: How many patients were treated in the past 3 months for gastric and gastro-oesophageal junction cancer (any stage) with: • CAPOX (Capecitabine with Oxaliplatin) • FOLFOX (Folinic acid, Fluorouracil and Oxaliplatin) • Pembrolizumab in combination with Platinum (Cisplatin or Oxaliplatin) and Fluoropyrimidine (5-Fluorouracil or Capecitabine) • Any other systemic anti-cancer therapy • Palliative care only

Answer To Question 1: CAPOX 0 patients FOLFOX <5 patients Pembrolizumab in combination 0 patients Other SACT <5 patients There were <5 patients who had gastric or gastro-oesophageal cancer who were treated with palliative care only.

Question Number 2: How many patients were treated in the past 3 months for Oesophageal cancer (any stage) with: • Pembrolizumab in combination with Platinum (Cisplatin or Oxaliplatin) and Fluoropyrimidene (5-Fluorouracil or Capecitabine) • Platinum and Fluoropyrimidene based combination treatments (Cisplatin or Oxaliplatin with 5-Fluorouracil or Capecitabine) • Nivolumab monotherapy • Nivolumab and Ipilimumab • Any other systemic anti-cancer therapy • Palliative care only

Answer To Question 2: Pembrolizumab with platinum <5 patients Platinum with fluoropyrimidine <5 patients Nivolumab monotherapy <5 patients Nivolumab with ipilimumab 0 patients Other SACT 14 patients There were <5 patients who had oesophageal cancer who were treated with palliative care only.

Question Number 3: Please provide the total number of patients treated in the last 3 months with any systemic anti-cancer therapy for: • Oesophageal cancer (any type or stage) • Oesophageal adenocarcinoma (any stage) • Oesophageal squamous cell carcinoma (any stage) • Gastric cancer (any type or stage) • Cancer of the gastro-oesophageal junction (any stage)

Answer To Question 3: Oesophageal cancer 15 Oesophageal adeno 5 patients Oseophageal squamous 0 patients (although histology wasn’t listed on Aria for 10 patients) Gastric cancer 5 patients Gastro-oesophageal 0 patients

To return to the list of all the FOI requests please click here

Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.